カテゴリー： Market Monitor Global, 世界, 医療/バイオ

スルホンアミドの世界市場見通し2023年-2029年

◆英語タイトル：Sulphonamides Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8690 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Sulphonamides Market 調査レポートは次の情報を含め、グローバルにおけるのスルホンアミド市場規模と予測を収録しています。・世界のスルホンアミド市場：売上、2018年-2023年、2024年-2029年
・世界のスルホンアミド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のスルホンアミド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口吸収性スルホンアミド」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

スルホンアミドのグローバル主要企業は、Abbott Laboratories、 Boehringer Ingelheim Pharmaceuticals、 Bayer AG、 GlaxoSmithKline、 King Pharmaceuticals、 Mylan Pharmaceuticals、 Novartis International AG、 Pfizer、 Par Pharmaceutical、 Roche Holding AG、 Sanofi Aventis、 Stiefel Laboratoriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、スルホンアミドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のスルホンアミド市場：タイプ別、2018年-2023年、2024年-2029年
世界のスルホンアミド市場：タイプ別市場シェア、2022年
・経口吸収性スルホンアミド、経口非吸収性スルホンアミド（スルファサルジン、オサラジン）、外用剤（スルファジアジン銀、スルファセトアミド、マフェニド）

世界のスルホンアミド市場：用途別、2018年-2023年、2024年-2029年
世界のスルホンアミド市場：用途別市場シェア、2022年
・皮膚感染症、胃腸管（GIT）感染症、髄膜炎

世界のスルホンアミド市場：地域・国別、2018年-2023年、2024年-2029年
世界のスルホンアミド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるスルホンアミドのグローバル売上、2018年-2023年
・主要企業におけるスルホンアミドのグローバル売上シェア、2022年
・主要企業におけるスルホンアミドのグローバル販売量、2018年-2023年
・主要企業におけるスルホンアミドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott Laboratories、 Boehringer Ingelheim Pharmaceuticals、 Bayer AG、 GlaxoSmithKline、 King Pharmaceuticals、 Mylan Pharmaceuticals、 Novartis International AG、 Pfizer、 Par Pharmaceutical、 Roche Holding AG、 Sanofi Aventis、 Stiefel Laboratories

*************************************************************

・調査・分析レポートの概要
スルホンアミド市場の定義
市場セグメント
世界のスルホンアミド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のスルホンアミド市場規模
世界のスルホンアミド市場規模：2022年 VS 2029年
世界のスルホンアミド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのスルホンアミドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のスルホンアミド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口吸収性スルホンアミド、経口非吸収性スルホンアミド（スルファサルジン、オサラジン）、外用剤（スルファジアジン銀、スルファセトアミド、マフェニド）
スルホンアミドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：皮膚感染症、胃腸管（GIT）感染症、髄膜炎
スルホンアミドの用途別グローバル売上・予測

・地域別市場分析
地域別スルホンアミド市場規模 2022年と2029年
地域別スルホンアミド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott Laboratories、 Boehringer Ingelheim Pharmaceuticals、 Bayer AG、 GlaxoSmithKline、 King Pharmaceuticals、 Mylan Pharmaceuticals、 Novartis International AG、 Pfizer、 Par Pharmaceutical、 Roche Holding AG、 Sanofi Aventis、 Stiefel Laboratories
...

Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
This report aims to provide a comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulphonamides. This report contains market size and forecasts of Sulphonamides in global, including the following market information:
Global Sulphonamides Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Sulphonamides Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Sulphonamides companies in 2022 (%)
The global Sulphonamides market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Orally Absorbable Sulfonamide Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sulphonamides include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sulphonamides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sulphonamides Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, by Type, 2022 (%)
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Global Sulphonamides Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, by Application, 2022 (%)
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Global Sulphonamides Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Sulphonamides Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sulphonamides revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sulphonamides revenues share in global market, 2022 (%)
Key companies Sulphonamides sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Sulphonamides sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sulphonamides, market overview.
Chapter 2: Global Sulphonamides market size in revenue and volume.
Chapter 3: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sulphonamides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sulphonamides capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Sulphonamides Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sulphonamides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sulphonamides Overall Market Size
2.1 Global Sulphonamides Market Size: 2022 VS 2029
2.2 Global Sulphonamides Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Sulphonamides Sales: 2018-2029
3 Company Landscape
3.1 Top Sulphonamides Players in Global Market
3.2 Top Global Sulphonamides Companies Ranked by Revenue
3.3 Global Sulphonamides Revenue by Companies
3.4 Global Sulphonamides Sales by Companies
3.5 Global Sulphonamides Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sulphonamides Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sulphonamides Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sulphonamides Players in Global Market
3.8.1 List of Global Tier 1 Sulphonamides Companies
3.8.2 List of Global Tier 2 and Tier 3 Sulphonamides Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Sulphonamides Market Size Markets, 2022 & 2029
4.1.2 Orally Absorbable Sulfonamide
4.1.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
4.1.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
4.2 By Type – Global Sulphonamides Revenue & Forecasts
4.2.1 By Type – Global Sulphonamides Revenue, 2018-2023
4.2.2 By Type – Global Sulphonamides Revenue, 2024-2029
4.2.3 By Type – Global Sulphonamides Revenue Market Share, 2018-2029
4.3 By Type – Global Sulphonamides Sales & Forecasts
4.3.1 By Type – Global Sulphonamides Sales, 2018-2023
4.3.2 By Type – Global Sulphonamides Sales, 2024-2029
4.3.3 By Type – Global Sulphonamides Sales Market Share, 2018-2029
4.4 By Type – Global Sulphonamides Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sulphonamides Market Size, 2022 & 2029
5.1.2 Skin Infections
5.1.3 Gastro Intestinal Tract (GIT) Infection
5.1.4 Meningitis
5.2 By Application – Global Sulphonamides Revenue & Forecasts
5.2.1 By Application – Global Sulphonamides Revenue, 2018-2023
5.2.2 By Application – Global Sulphonamides Revenue, 2024-2029
5.2.3 By Application – Global Sulphonamides Revenue Market Share, 2018-2029
5.3 By Application – Global Sulphonamides Sales & Forecasts
5.3.1 By Application – Global Sulphonamides Sales, 2018-2023
5.3.2 By Application – Global Sulphonamides Sales, 2024-2029
5.3.3 By Application – Global Sulphonamides Sales Market Share, 2018-2029
5.4 By Application – Global Sulphonamides Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Sulphonamides Market Size, 2022 & 2029
6.2 By Region – Global Sulphonamides Revenue & Forecasts
6.2.1 By Region – Global Sulphonamides Revenue, 2018-2023
6.2.2 By Region – Global Sulphonamides Revenue, 2024-2029
6.2.3 By Region – Global Sulphonamides Revenue Market Share, 2018-2029
6.3 By Region – Global Sulphonamides Sales & Forecasts
6.3.1 By Region – Global Sulphonamides Sales, 2018-2023
6.3.2 By Region – Global Sulphonamides Sales, 2024-2029
6.3.3 By Region – Global Sulphonamides Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Sulphonamides Revenue, 2018-2029
6.4.2 By Country – North America Sulphonamides Sales, 2018-2029
6.4.3 US Sulphonamides Market Size, 2018-2029
6.4.4 Canada Sulphonamides Market Size, 2018-2029
6.4.5 Mexico Sulphonamides Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Sulphonamides Revenue, 2018-2029
6.5.2 By Country – Europe Sulphonamides Sales, 2018-2029
6.5.3 Germany Sulphonamides Market Size, 2018-2029
6.5.4 France Sulphonamides Market Size, 2018-2029
6.5.5 U.K. Sulphonamides Market Size, 2018-2029
6.5.6 Italy Sulphonamides Market Size, 2018-2029
6.5.7 Russia Sulphonamides Market Size, 2018-2029
6.5.8 Nordic Countries Sulphonamides Market Size, 2018-2029
6.5.9 Benelux Sulphonamides Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Sulphonamides Revenue, 2018-2029
6.6.2 By Region – Asia Sulphonamides Sales, 2018-2029
6.6.3 China Sulphonamides Market Size, 2018-2029
6.6.4 Japan Sulphonamides Market Size, 2018-2029
6.6.5 South Korea Sulphonamides Market Size, 2018-2029
6.6.6 Southeast Asia Sulphonamides Market Size, 2018-2029
6.6.7 India Sulphonamides Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Sulphonamides Revenue, 2018-2029
6.7.2 By Country – South America Sulphonamides Sales, 2018-2029
6.7.3 Brazil Sulphonamides Market Size, 2018-2029
6.7.4 Argentina Sulphonamides Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Sulphonamides Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Sulphonamides Sales, 2018-2029
6.8.3 Turkey Sulphonamides Market Size, 2018-2029
6.8.4 Israel Sulphonamides Market Size, 2018-2029
6.8.5 Saudi Arabia Sulphonamides Market Size, 2018-2029
6.8.6 UAE Sulphonamides Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Sulphonamides Major Product Offerings
7.1.4 Abbott Laboratories Sulphonamides Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Boehringer Ingelheim Pharmaceuticals
7.2.1 Boehringer Ingelheim Pharmaceuticals Company Summary
7.2.2 Boehringer Ingelheim Pharmaceuticals Business Overview
7.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Major Product Offerings
7.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales and Revenue in Global (2018-2023)
7.2.5 Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Sulphonamides Major Product Offerings
7.3.4 Bayer AG Sulphonamides Sales and Revenue in Global (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Sulphonamides Major Product Offerings
7.4.4 GlaxoSmithKline Sulphonamides Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 King Pharmaceuticals
7.5.1 King Pharmaceuticals Company Summary
7.5.2 King Pharmaceuticals Business Overview
7.5.3 King Pharmaceuticals Sulphonamides Major Product Offerings
7.5.4 King Pharmaceuticals Sulphonamides Sales and Revenue in Global (2018-2023)
7.5.5 King Pharmaceuticals Key News & Latest Developments
7.6 Mylan Pharmaceuticals
7.6.1 Mylan Pharmaceuticals Company Summary
7.6.2 Mylan Pharmaceuticals Business Overview
7.6.3 Mylan Pharmaceuticals Sulphonamides Major Product Offerings
7.6.4 Mylan Pharmaceuticals Sulphonamides Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Pharmaceuticals Key News & Latest Developments
7.7 Novartis International AG
7.7.1 Novartis International AG Company Summary
7.7.2 Novartis International AG Business Overview
7.7.3 Novartis International AG Sulphonamides Major Product Offerings
7.7.4 Novartis International AG Sulphonamides Sales and Revenue in Global (2018-2023)
7.7.5 Novartis International AG Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Sulphonamides Major Product Offerings
7.8.4 Pfizer Sulphonamides Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Par Pharmaceutical
7.9.1 Par Pharmaceutical Company Summary
7.9.2 Par Pharmaceutical Business Overview
7.9.3 Par Pharmaceutical Sulphonamides Major Product Offerings
7.9.4 Par Pharmaceutical Sulphonamides Sales and Revenue in Global (2018-2023)
7.9.5 Par Pharmaceutical Key News & Latest Developments
7.10 Roche Holding AG
7.10.1 Roche Holding AG Company Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Sulphonamides Major Product Offerings
7.10.4 Roche Holding AG Sulphonamides Sales and Revenue in Global (2018-2023)
7.10.5 Roche Holding AG Key News & Latest Developments
7.11 Sanofi Aventis
7.11.1 Sanofi Aventis Company Summary
7.11.2 Sanofi Aventis Sulphonamides Business Overview
7.11.3 Sanofi Aventis Sulphonamides Major Product Offerings
7.11.4 Sanofi Aventis Sulphonamides Sales and Revenue in Global (2018-2023)
7.11.5 Sanofi Aventis Key News & Latest Developments
7.12 Stiefel Laboratories
7.12.1 Stiefel Laboratories Company Summary
7.12.2 Stiefel Laboratories Sulphonamides Business Overview
7.12.3 Stiefel Laboratories Sulphonamides Major Product Offerings
7.12.4 Stiefel Laboratories Sulphonamides Sales and Revenue in Global (2018-2023)
7.12.5 Stiefel Laboratories Key News & Latest Developments
8 Global Sulphonamides Production Capacity, Analysis
8.1 Global Sulphonamides Production Capacity, 2018-2029
8.2 Sulphonamides Production Capacity of Key Manufacturers in Global Market
8.3 Global Sulphonamides Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sulphonamides Supply Chain Analysis
10.1 Sulphonamides Industry Value Chain
10.2 Sulphonamides Upstream Market
10.3 Sulphonamides Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sulphonamides Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Sulphonamides in Global Market
Table 2. Top Sulphonamides Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sulphonamides Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Sulphonamides Revenue Share by Companies, 2018-2023
Table 5. Global Sulphonamides Sales by Companies, (K MT), 2018-2023
Table 6. Global Sulphonamides Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Sulphonamides Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Sulphonamides Product Type
Table 9. List of Global Tier 1 Sulphonamides Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sulphonamides Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Sulphonamides Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Sulphonamides Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Sulphonamides Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Sulphonamides Sales (K MT), 2018-2023
Table 15. By Type - Global Sulphonamides Sales (K MT), 2024-2029
Table 16. By Application – Global Sulphonamides Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Sulphonamides Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Sulphonamides Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Sulphonamides Sales (K MT), 2018-2023
Table 20. By Application - Global Sulphonamides Sales (K MT), 2024-2029
Table 21. By Region – Global Sulphonamides Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Sulphonamides Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Sulphonamides Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Sulphonamides Sales (K MT), 2018-2023
Table 25. By Region - Global Sulphonamides Sales (K MT), 2024-2029
Table 26. By Country - North America Sulphonamides Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Sulphonamides Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Sulphonamides Sales, (K MT), 2018-2023
Table 29. By Country - North America Sulphonamides Sales, (K MT), 2024-2029
Table 30. By Country - Europe Sulphonamides Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Sulphonamides Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Sulphonamides Sales, (K MT), 2018-2023
Table 33. By Country - Europe Sulphonamides Sales, (K MT), 2024-2029
Table 34. By Region - Asia Sulphonamides Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Sulphonamides Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Sulphonamides Sales, (K MT), 2018-2023
Table 37. By Region - Asia Sulphonamides Sales, (K MT), 2024-2029
Table 38. By Country - South America Sulphonamides Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Sulphonamides Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Sulphonamides Sales, (K MT), 2018-2023
Table 41. By Country - South America Sulphonamides Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Sulphonamides Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Sulphonamides Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Sulphonamides Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Sulphonamides Sales, (K MT), 2024-2029
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories Sulphonamides Product Offerings
Table 48. Abbott Laboratories Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Boehringer Ingelheim Pharmaceuticals Company Summary
Table 51. Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Offerings
Table 52. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Boehringer Ingelheim Pharmaceuticals Key News & Latest Developments
Table 54. Bayer AG Company Summary
Table 55. Bayer AG Sulphonamides Product Offerings
Table 56. Bayer AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Bayer AG Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Sulphonamides Product Offerings
Table 60. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. King Pharmaceuticals Company Summary
Table 63. King Pharmaceuticals Sulphonamides Product Offerings
Table 64. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. King Pharmaceuticals Key News & Latest Developments
Table 66. Mylan Pharmaceuticals Company Summary
Table 67. Mylan Pharmaceuticals Sulphonamides Product Offerings
Table 68. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Mylan Pharmaceuticals Key News & Latest Developments
Table 70. Novartis International AG Company Summary
Table 71. Novartis International AG Sulphonamides Product Offerings
Table 72. Novartis International AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Novartis International AG Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Sulphonamides Product Offerings
Table 76. Pfizer Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Par Pharmaceutical Company Summary
Table 79. Par Pharmaceutical Sulphonamides Product Offerings
Table 80. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Par Pharmaceutical Key News & Latest Developments
Table 82. Roche Holding AG Company Summary
Table 83. Roche Holding AG Sulphonamides Product Offerings
Table 84. Roche Holding AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Roche Holding AG Key News & Latest Developments
Table 86. Sanofi Aventis Company Summary
Table 87. Sanofi Aventis Sulphonamides Product Offerings
Table 88. Sanofi Aventis Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Sanofi Aventis Key News & Latest Developments
Table 90. Stiefel Laboratories Company Summary
Table 91. Stiefel Laboratories Sulphonamides Product Offerings
Table 92. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Stiefel Laboratories Key News & Latest Developments
Table 94. Sulphonamides Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 95. Global Sulphonamides Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Sulphonamides Production by Region, 2018-2023 (K MT)
Table 97. Global Sulphonamides Production by Region, 2024-2029 (K MT)
Table 98. Sulphonamides Market Opportunities & Trends in Global Market
Table 99. Sulphonamides Market Drivers in Global Market
Table 100. Sulphonamides Market Restraints in Global Market
Table 101. Sulphonamides Raw Materials
Table 102. Sulphonamides Raw Materials Suppliers in Global Market
Table 103. Typical Sulphonamides Downstream
Table 104. Sulphonamides Downstream Clients in Global Market
Table 105. Sulphonamides Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sulphonamides Segment by Type in 2022
Figure 2. Sulphonamides Segment by Application in 2022
Figure 3. Global Sulphonamides Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sulphonamides Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Sulphonamides Revenue, 2018-2029 (US$, Mn)
Figure 7. Sulphonamides Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Sulphonamides Revenue in 2022
Figure 9. By Type - Global Sulphonamides Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Sulphonamides Revenue Market Share, 2018-2029
Figure 11. By Type - Global Sulphonamides Sales Market Share, 2018-2029
Figure 12. By Type - Global Sulphonamides Price (USD/MT), 2018-2029
Figure 13. By Application - Global Sulphonamides Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Sulphonamides Revenue Market Share, 2018-2029
Figure 15. By Application - Global Sulphonamides Sales Market Share, 2018-2029
Figure 16. By Application - Global Sulphonamides Price (USD/MT), 2018-2029
Figure 17. By Region - Global Sulphonamides Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Sulphonamides Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Sulphonamides Revenue Market Share, 2018-2029
Figure 20. By Region - Global Sulphonamides Sales Market Share, 2018-2029
Figure 21. By Country - North America Sulphonamides Revenue Market Share, 2018-2029
Figure 22. By Country - North America Sulphonamides Sales Market Share, 2018-2029
Figure 23. US Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Sulphonamides Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Sulphonamides Sales Market Share, 2018-2029
Figure 28. Germany Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 29. France Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Sulphonamides Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Sulphonamides Sales Market Share, 2018-2029
Figure 37. China Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 41. India Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Sulphonamides Revenue Market Share, 2018-2029
Figure 43. By Country - South America Sulphonamides Sales Market Share, 2018-2029
Figure 44. Brazil Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Sulphonamides Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Sulphonamides Sales Market Share, 2018-2029
Figure 48. Turkey Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Sulphonamides Revenue, (US$, Mn), 2018-2029
Figure 52. Global Sulphonamides Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Sulphonamides by Region, 2022 VS 2029
Figure 54. Sulphonamides Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ スルホンアミドの世界市場見通し2023年-2029年(Sulphonamides Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

スルホンアミドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp